AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 57 filers reported holding AEROVATE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | – | 229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $12,177,880 | 24.30% |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $41,131,652 | 5.57% |
| Sofinnova Investments, Inc. | 3,758,686 | $75,812,697 | 4.85% |
| TCG Crossover Management, LLC | 1,081,274 | $21,809,297 | 4.25% |
| RA Capital Management | 8,263,982 | $166,684,517 | 3.77% |
| VR Adviser, LLC | 833,927 | $16,820,308 | 3.28% |
| GREAT POINT PARTNERS LLC | 755,620 | $15,240,855 | 2.99% |
| Cormorant Asset Management, LP | 1,561,696 | $31,499 | 2.07% |
| Octagon Capital Advisors LP | 621,712 | $12,539,931 | 1.80% |
| Ghost Tree Capital, LLC | 200,000 | $4,034,000 | 1.19% |